// App-Quantinova.ai

612 : Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period

Researchers

Presenter

  • Regan Arendse

Principal Investigators

  • Anna Jaroszynska

  • Derek Haaland

  • Pauline Boulos

  • Isabelle Fortin

  • Raheem Kherani

  • Ariel Masetto

  • Jonathan Chan

  • Eliofotisti Psaradellis

  • Melissa Stutz

  • Brendan Osborne

  • Francois Nantel

  • Allen J Lehman

Medical Centers

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Private Practice, Burlington, ON, Canada

  • Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • Centre de Rhumatologie de -Est du Quebec, Rimouski, QC, Canada

  • Univ of British Columbia, Richmond, Canada

  • Centre hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Medical Affairs, Janssen Inc., Toronto, ON, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

  • Infliximab

  • golimumab

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved